Number of Patients per Cohort and Sample Size Considerations Using Dose Escalation with Overdose Control
The main objective of cancer phase I clinical trials is to determine a maximum tolerated dose (MTD) of a new experimental treatment. In practice, most of these trials are designed so that three patients per cohort are treated at the same dose level. In this paper, we compare the safety and efficienc...
Saved in:
Main Authors: | Mourad Tighiouart, André Rogatko |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Journal of Probability and Statistics |
Online Access: | http://dx.doi.org/10.1155/2012/692725 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Importance of Dose Escalation in the Treatment of Pulmonary Arterial Hypertension with Treprostinil
by: Piotr Kędzierski, et al.
Published: (2025-01-01) -
A Bayesian Adaptive Design in Cancer Phase I Trials Using Dose Combinations in the Presence of a Baseline Covariate
by: Márcio Augusto Diniz, et al.
Published: (2018-01-01) -
Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity
by: David Thomson, et al.
Published: (2012-01-01) -
Finding new ways to treat overdoses
by: Jill R Turner, et al.
Published: (2025-01-01) -
Acute Renal Failure Secondary to Inadvertent Propylene Glycol Overdose with Single-Day High-Dose Vitamin D (Stosstherapy)
by: David H. Jelley, et al.
Published: (2019-01-01)